https://www.selleckchem.com/pr....oducts/way-100635.ht
Development and implementation of standardized criteria and methods of assessment for tenders may avoid manufacturers facing segmented markets, encourage competition and the longer-term sustainability of biosimilars, and realize the healthcare system and patient benefits these treatments can bring. © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor Francis Group.In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personaliz
Like
Comment
Share
